Trial intelligence / Profile preview

NaCeD: Hookworm and Gluten Tolerance in Celiac Disease

NCT01661933Phase 2Completed

Sponsor
The Prince Charles Hospital
Start
Aug 2012
Primary completion
Mar 2014
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 2 trial of Necator americanus larvae in celiac disease, sponsored by The Prince Charles Hospital. Started Aug 2012; status: completed.

02

Drugs

Necator americanus larvae
03

Conditions

celiac disease

Beyond the preview

Go deeper on NCT01661933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01661933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call